High-Content Assay Multiplexing for Toxicity Screening in Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Hepatocytes

Cell-based high-content screening (HCS) assays have become an increasingly attractive alternative to traditional in vitro and in vivo testing in pharmaceutical drug development and toxicological safety assessment. The time- and cost-effectiveness of HCS assays, combined with the organotypic nature o...

Descripción completa

Detalles Bibliográficos
Autores principales: Grimm, Fabian Alexander, Iwata, Yasuhiro, Sirenko, Oksana, Bittner, Michael, Rusyn, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652224/
https://www.ncbi.nlm.nih.gov/pubmed/26539751
http://dx.doi.org/10.1089/adt.2015.659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652224/
https://www.ncbi.nlm.nih.gov/pubmed/26539751
http://dx.doi.org/10.1089/adt.2015.659

Ejemplares similares